What type of study is this?

This is a Pre-Registered Trial study.

December 8, 2025BloodOpen Access

Performance of radiomics features in patients with peripheral T-cell lymphoma: Data from international prospective T-cell project 2.0

View Full Paper

Ask AI

Bookmark

Authors

Analysis shows peripheral T-cell lymphoma prognosis links to radiomics features, highlighting treatment response assessment implications.

Overall survival and progression free survival in peripheral T-cell lymphoma patients relate to TMTV and clinical factors.
Confirmed data from 138 patients with a median follow-up of 39 months reveal significant prognostic characteristics.
Assessment using FDG-PET supports radiomic index as a promising tool for treatment response evaluation.
Findings imply that robust risk stratification is crucial for managing peripheral T-cell lymphoma effectively.

Skrypets et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Analysis shows peripheral T-cell lymphoma prognosis links to radiomics features, highlighting treatment response assessment implications.

Overall survival and progression free survival in peripheral T-cell lymphoma patients relate to TMTV and clinical factors.
Confirmed data from 138 patients with a median follow-up of 39 months reveal significant prognostic characteristics.
Assessment using FDG-PET supports radiomic index as a promising tool for treatment response evaluation.
Findings imply that robust risk stratification is crucial for managing peripheral T-cell lymphoma effectively.

Skrypets et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark